We are live on ! Find out more
ATNM icon

Actinium Pharmaceuticals
ATNM

27 hedge funds and large institutions have $4.33M invested in Actinium Pharmaceuticals in 2015 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 8 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

25% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 8

0.02% less ownership

Funds ownership: 0.22% → 0.2% (-0.02%)

31% less funds holding

Funds holding: 39 → 27 (-12)

35% less capital invested

Capital invested by funds: $6.63M → $4.33M (-$2.3M)

75% less call options, than puts

Call options by funds: $35K | Put options by funds: $138K

80% less first-time investments, than exits

New positions opened: 3 | Existing positions closed: 15

Holders
27
Holders Change
-12
Holders Change %
-30.77%
% of All Funds
0.75%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
10
Reduced
8
Closed
15
Calls
$35K
Puts
$138K
Net Calls
-$103K
Net Calls Change
+$11K

Top Buyers

Rank Fund Capital Flow
1
BIT
BlackRock Institutional Trust
California
+$683K
2
Vanguard Group
Vanguard Group
Pennsylvania
+$257K
3
SM
Sabby Management
Florida
+$152K
4
BCM
Bridgeway Capital Management
Texas
+$103K
5
Deutsche Bank
Deutsche Bank
Germany
+$64.2K

Top Sellers

Rank Fund Capital Flow
1
Northern Trust
Northern Trust
Illinois
-$427K
2
TCIM
TIAA CREF Investment Management
New York
-$304K
3
Squarepoint
Squarepoint
New York
-$138K
4
Jane Street
Jane Street
New York
-$129K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
-$118K
Name Holding Trade Value Shares
Change 		Change in
Stake
AIG
26
American International Group
New York
$4K +$2.67K +40 +108%
TCIM
27
TIAA CREF Investment Management
New York
– -$304K -3,819 Closed
Squarepoint
28
Squarepoint
New York
– -$138K -1,737 Closed
Jane Street
29
Jane Street
New York
– -$129K -1,627 Closed
COPPSERS
30
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
– -$118K -1,481 Closed
PP
31
Paloma Partners
Connecticut
– -$102K -1,285 Closed
AGM
32
Alpine Global Management
New York
– -$45K -566 Closed
RCM
33
Rotella Capital Management
Washington
– -$29K -360 Closed
New York State Common Retirement Fund
34
New York State Common Retirement Fund
New York
– -$23K -293 Closed
JG
35
Jefferies Group
New York
– -$20K -252 Closed
Wells Fargo
36
Wells Fargo
California
– -$10K -122 Closed
Bank of America
37
Bank of America
North Carolina
– -$5K -58 Closed
Canada Life
38
Canada Life
Manitoba, Canada
– -$4K -46 Closed
WCM
39
Westend Capital Management
California
– -$2K -33 Closed
Barclays
40
Barclays
United Kingdom
– -$1K -14 Closed
UBS Group
41
UBS Group
Switzerland
– -$1K -13 Closed
1
2

ATNM Hedge Fund Activity: Q3 2015 in Review

27 of the 3,582 institutional investors tracked by Wall St. Rank reported a position in Actinium Pharmaceuticals (ATNM) for Q3 2015, worth a combined $4.33M — down 35% from $6.63M a quarter earlier.

Sellers outnumbered buyers: 15 funds closed out of ATNM and 3 opened new positions — a net loss of 12 holders — while 8 trimmed existing stakes and 10 added.

The largest buyer was BlackRock Institutional Trust, opening a new position worth an estimated $683K. The largest seller was Northern Trust, cutting an estimated $427K.

  • 27 institutional investors held Actinium Pharmaceuticals (ATNM) as of Q3 2015, down from 39 in Q2 2015.
  • Funds reported $4.33M of Actinium Pharmaceuticals stock for Q3 2015, down 35% quarter-over-quarter.
  • 3 funds opened new Actinium Pharmaceuticals positions in Q3 2015 and 15 closed out, a net change of -12 holders.
  • The largest Actinium Pharmaceuticals buyer in Q3 2015 was BlackRock Institutional Trust, an estimated $683K added.
  • The largest Actinium Pharmaceuticals seller in Q3 2015 was Northern Trust, an estimated $427K sold.

Based on aggregated 13F filings for Q3 2015.